Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Change in Account Payables: 2018-2024

Historic Change in Account Payables for Arcutis Biotherapeutics (ARQT) over the last 7 years, with Dec 2024 value amounting to $2.2 million.

  • Arcutis Biotherapeutics' Change in Account Payables fell 242.76% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year decrease of 847.59%. This contributed to the annual value of $2.2 million for FY2024, which is 29.28% down from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Change in Account Payables stood at $2.2 million for FY2024, which was down 29.28% from $3.2 million recorded in FY2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Change in Account Payables peaked at $5.7 million during FY2020, and registered a low of $245,000 during FY2021.
  • Moreover, its 3-year median value for Change in Account Payables was $2.2 million (2024), whereas its average is $2.3 million.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Change in Account Payables surged by 1,338.86% in 2020, and later plummeted by 95.68% in 2021.
  • Arcutis Biotherapeutics' Change in Account Payables (Yearly) stood at $5.7 million in 2020, then plummeted by 95.68% to $245,000 in 2021, then surged by 538.78% to $1.6 million in 2022, then skyrocketed by 101.41% to $3.2 million in 2023, then fell by 29.28% to $2.2 million in 2024.